Quantify cell adhesion, rolling, migration, cell-cell adhesion, platelet aggregation, thrombi formation - all under shear flow

Thrombosis | Inflammation | Atherosclerosis | Engineered microcapillaries | Automated highthroughput flow assay for shear stress experiment

Platelet adhesion and aggregation under flow | C604 alters the cell's major biophysical properties | Set the shear rate to model thrombosis

Quantify cell adhesion, rolling, migration, cell-cell adhesion, platelet aggregation, thrombi formation - all under shear flow.

Novel microflow system | Low flow rates (5 pL min-1 to 10 μL min-1) and shear stress levels

Quantify cell adhesion, rolling, migration, cell-cell adhesion, platelet aggregation, thrombi ormation - all under shear flow.

Role of SHARPIN in regulating platelet function | Perfusing whole blood | Accumulation on collagen | Reduced linear ubiquitination

Role of different stimuli recognised to play an important part in atherosclerosis development | Leukocyte adhesion to endothelial cells |

Targeting assays | fluorescence microscopy | miRNA-based therapeutics in atherothrombotic diseases

Thrombus formation under flow in vitro | Treatment with cucurbitacin | Pre-incubation of platelets with cucurbitacins

Inhibition of human blood platelets aggregation | Inhibition of human blood platelets aggregation | Formation of thrombus in flow conditions

The tyrosine kinase JAK2 protein is critical for the JAK/STAT cytokine signaling of hematopoietic cells. The somatic JAK2 V617F mutation...

Microfluidic studies | Neutrophil-targeted ROS-inhibition assays | Thrombus formation in HIT requires neutrophil-derived ROS

NETosis markers | Thrombosis induction | VITT antibodies induce thrombosis and thrombocytopenia in vitro

Thrombus Formation | Integrin αIIbβ3 Signaling | Granule Secretion in Platelets | Hemostasis

How does the nanovesicle work | Thrombus selectivity under physiological flow conditions | Targeted thrombolysis under flow conditions |

On this World Thrombosis Day and in advance of World Stroke Day, taking place on 29th October, we’d like to shine a light on a paper recentl

New study reveals blood clotting in critically ill COVID-19 may be caused by an excessive immune response rather than the virus itself.

Congenital thrombotic thrombocytopenic purpura (cTTP) is a rare blood clotting disorder. Currently, there is no method to assess the...

As a thrombus (blood clot) grows in size, the blood has to be diverted over and around it. In order for blood flow to be maintained, the blo